daraxonrasib   Click here for help

GtoPdb Ligand ID: 13368

Synonyms: RAS Inhibitor A122 | Rasonque® | RMC-6236 | RMC6236
Approved drug
daraxonrasib is an approved drug
Compound class: Synthetic organic
Comment: RMC-6236 is a macrocyclic, noncovalent (reversible) pan-RAS inhibitor [1-2]. It was developed using structure-guided design from the bacterial polyketide Sanglifehrin A. RMC-6236 forms a binary complex with the ubiquitously-expressed chaperone protein cyclophilin A. The binary complex has high affinity for RAS proteins, and interactions lead to the formation of an inhibitory tri-complex [4]. RMC-6236 has activity against active state (GTP-bound) mutant and wild-type RAS proteins. This mode of action is described as RAS(ON) inhibition, and is intended to target tumours with oncogenic RAS mutations beyond the common driver mutation KRASG12C [2]. The chemical structure of RMC-6236 is identical to that for the INN daraxonrasib (proposed list 132, Feb. 2025).
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 13
Hydrogen bond donors 2
Rotatable bonds 8
Topological polar surface area 156.71
Molecular weight 811.05
XLogP 5.08
No. Lipinski's rules broken 3

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCN1C2=C3C=C(C=C2)C4=CSC(=N4)C[C@@H](C(=O)N5CCC[C@@H](C(=O)OCC(C)(C)CC3=C1C6=C([C@H](C)OC)N=CC(=C6)N7CCN(C)CC7)N5)NC(=O)[C@H]8C[C@@H]8C
Isomeric SMILES CCN1C2=C3C=C(C=C2)C4=CSC(=N4)C[C@@H](C(=O)N5CCC[C@H](N5)C(=O)OCC(CC3=C1C6=C(N=CC(=C6)N7CCN(CC7)C)[C@H](C)OC)(C)C)NC(=O)[C@H]8C[C@@H]8C
InChI InChI=1S/C44H58N8O5S/c1-8-51-37-12-11-28-19-31(37)33(40(51)32-20-29(23-45-39(32)27(3)56-7)50-16-14-49(6)15-17-50)22-44(4,5)25-57-43(55)34-10-9-13-52(48-34)42(54)35(21-38-46-36(28)24-58-38)47-41(53)30-18-26(30)2/h11-12,19-20,23-24,26-27,30,34-35,48H,8-10,13-18,21-22,25H2,1-7H3,(H,47,53)/t26-,27-,30-,34-,35-/m0/s1
InChI Key FVICRBSEYSHKFY-JYQNNKODSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

Classification Click here for help
Compound class Synthetic organic
Approved drug? Yes. US FDA (2026)
International Nonproprietary Names Click here for help
INN number INN
13270 daraxonrasib
Synonyms Click here for help
RAS Inhibitor A122 | Rasonque® | RMC-6236 | RMC6236
Database Links Click here for help
CAS Registry No. 2765081-21-6 (source: WHO INN record)
GtoPdb PubChem SID 496703338
PubChem CID 164726578
Search Google for chemical match using the InChIKey FVICRBSEYSHKFY-JYQNNKODSA-N
Search Google for chemicals with the same backbone FVICRBSEYSHKFY
Search PubMed clinical trials daraxonrasib
Search PubMed titles daraxonrasib
Search PubMed titles/abstracts daraxonrasib
UniChem Compound Search for chemical match using the InChIKey FVICRBSEYSHKFY-JYQNNKODSA-N
UniChem Connectivity Search for chemical match using the InChIKey FVICRBSEYSHKFY-JYQNNKODSA-N

Product suppliers

View disclaimer

MedChemExpress
Daraxonrasib (links to external site)
Cat. No. HY-148439